Normal platelet mitochondrial complex I activity in Huntington’s Disease

Normal platelet mitochondrial complex I activity in Huntington’s Disease

Two small case series of platelet mitochondrial complex I activity assays in Huntington’s Disease (HD) report discrepant results. We measured platelet complex I and complex I/III activity in 21 subjects with early gene-positive HD and 14 age-matched controls. The 21 participants with HD that we stud...

Full description

Bibliographic Details
Main Authors:	William J. Powers, Richard H. Haas, Thuy Le, Tom O. Videen, Tamara Hershey, Lori McGee-Minnich, Joel S. Perlmutter
Format:	Article
Language:	English
Published:	Elsevier 2007-07-01
Series:	Neurobiology of Disease
Subjects:	Huntington’s Disease Mitochondria Electron transport system Platelets Human
Online Access:	http://www.sciencedirect.com/science/article/pii/S0969996107000915

Similar Items

Mitochondrial dynamics and quality control in Huntington's disease
by: Pedro Guedes-Dias, et al.
Published: (2016-06-01)

Oxidative metabolism and mitochondrial calcium handling in mouse models of Huntington's Disease
by: Hamilton, James M.
Published: (2017)

Mitochondrial Respiration Changes in R6/2 Huntington’s Disease Model Mice during Aging in a Brain Region Specific Manner
by: Johannes Burtscher, et al.
Published: (2020-07-01)

Sample Preparation as a Critical Aspect of Blood Platelet Mitochondrial Respiration Measurements—The Impact of Platelet Activation on Mitochondrial Respiration
by: Karolina Siewiera, et al.
Published: (2021-08-01)

Standardization of the assessment protocol of mitochondrial respiration in human platelets
by: Rațiu D. Corina, et al.
Published: (2016-12-01)

Cardiac dysfunction in the R6/2 mouse model of Huntington’s disease
by: Michael J. Mihm, et al.
Published: (2007-02-01)

Mitochondrial fission in Huntington's disease mouse striatum disrupts ER-mitochondria contacts leading to disturbances in Ca2+ efflux and Reactive Oxygen Species (ROS) homeostasis
by: Marta Cherubini, et al.
Published: (2020-03-01)

A Rationale for Hypoxic and Chemical Conditioning in Huntington’s Disease
by: Johannes Burtscher, et al.
Published: (2021-01-01)

Impaired Redox Signaling in Huntington’s Disease: Therapeutic Implications
by: Bindu D. Paul, et al.
Published: (2019-03-01)

Regulation of neuronal calcium homeostasis in Huntington's
by: Pellman, Jessica J.
Published: (2016)

Growth Hormone Deteriorates the Functional Outcome in an Experimental Model of Huntington’s Disease Induced by 3-Nitropionic Acid
by: Jung-Eun Park, et al.
Published: (2013-10-01)

Full length mutant huntingtin is required for altered Ca2+ signaling and apoptosis of striatal neurons in the YAC mouse model of Huntington's disease
by: Hua Zhang, et al.
Published: (2008-07-01)

Mutant huntingtin aggregates impair mitochondrial movement and trafficking in cortical neurons
by: Diane T.W. Chang, et al.
Published: (2006-05-01)

The association of VDAC with cell viability of PC12 model of Huntington’s disease
by: Andonis Karachitos, et al.
Published: (2016-11-01)

Mammals of the Huntington Reservoir, Huntington and Wells Counties, Indiana
by: Reising, Johnny W.
Published: (2011)

Huntington’s chorea and schizophrenia : amino acids in thalamus
by: Buchanan, Janet Ann
Published: (2010)

Juvenile Huntington disease in Argentina
by: Emilia Mabel Gatto, et al.
Published: (2015-01-01)

The use of olanzapine in Huntington disease accompanied by psychotic symptoms
by: Cafer Alhan, et al.
Published: (2014-06-01)

ROS in Platelet Biology: Functional Aspects and Methodological Insights
by: Elena Masselli, et al.
Published: (2020-07-01)

Physiotherapy in Huntington’s disease
by: Hanne Ludt Fossmo, et al.
Published: (2013-01-01)

New Insights into the Implication of Mitochondrial Dysfunction in Tissue, Peripheral Blood Mononuclear Cells, and Platelets during Lung Diseases
by: Marianne Riou, et al.
Published: (2020-04-01)

MRI findings in juvenile Huntington's disease
by: Patrick Arraj, BS, et al.
Published: (2021-01-01)

Huntington Hastalığında Dikkat Fonksiyonlarının Değerlendirilmesi
by: Murat Gültekin, et al.
Published: (2017-12-01)

Impact of Amyloid-β on Platelet Mitochondrial Function and Platelet–Mediated Amyloid Aggregation in Alzheimer’s Disease
by: Lili Donner, et al.
Published: (2021-09-01)

Juvenile Huntington's disease confirmed by genetic examination in twins Doença de Huntington juvenil confirmada por exame genético em gêmeas
by: GILBERTO LEVY, et al.
Published: (1999-09-01)

Huntington’s disease: The Indian perspective
by: Srinivas Raju, et al.
Published: (2021-01-01)

Unawareness of deficits in Huntington's disease
by: McGlynn, Susan Mary, 1960-
Published: (1989)

A molecular approach to Huntington disease in Southern Africa
by: Greenberg, Leslie J H L
Published: (2017)

Diagnosing Juvenile Huntington’s Disease: An Explorative Study among Caregivers of Affected Children
by: Mayke Oosterloo, et al.
Published: (2020-03-01)

Huntington Disease in Asia
by: Miao Xu, et al.
Published: (2015-01-01)

Perceptions about Research Participation among Individuals at Risk and Individuals with Premanifest Huntington’s Disease: A Survey Conducted by the European Huntington Association
by: Filipa Júlio, et al.
Published: (2021-08-01)

Mental disorders in Huntington’s disease
by: S. A. Klyushnikov, et al.
Published: (2014-01-01)

Clinical and genetic analysis of 29 Brazilian patients with Huntington's disease-like phenotype
by: Guilherme Riccioppo Rodrigues, et al.
Published: (2011-06-01)

Role of Platelet Mitochondria: Life in a Nucleus-Free Zone
by: Hannah Melchinger, et al.
Published: (2019-10-01)

Juvenile Huntington’s Disease Skin Fibroblasts Respond with Elevated Parkin Level and Increased Proteasome Activity as a Potential Mechanism to Counterbalance the Pathological Consequences of Mutant Huntingtin Protein
by: Azzam Aladdin, et al.
Published: (2019-10-01)

An animal model of Huntington’s disease : behavioral, pharmacological and morphological changes following intrastriatal injections of kainic acid
by: Sanberg, Paul Ronald
Published: (2010)

Adenyl cyclase activator forskolin protects against Huntington's disease-like neurodegenerative disorders
by: Sidharth Mehan, et al.
Published: (2017-01-01)

Huntington disease: Advances in the understanding of its mechanisms
by: Emilia M. Gatto, et al.
Published: (2020-01-01)

Genetic modifiers and therapeutic strategies in Huntington's disease
by: Underwood, Benjamin Russell
Published: (2011)

Amélioration d'un composé actif contre la maladie de Huntington
by: Marelli, Cecilia
Published: (2015)

Cannot write session to /tmp/vufind_sessions/sess_7lepb71celuk8mptldcfrhbgf2